← Back to Search

Smoking Cessation Support for Cervical Cancer Survivors

N/A

Recruiting

Led By Jennifer Vidrine, PhD, MS

Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 24 months

Awards & highlights

Study Summary

This trial will compare two different methods to help people with cervical cancer quit smoking: telephone counseling and personalized texts.

Who is the study for?

This trial is for individuals in Florida who have a history of cervical cancer or high-grade cervical dysplasia, currently smoke cigarettes, and have smoked at least 100 in their lifetime. They must speak English and own a working smartphone. People can't join if they live with someone already enrolled, cannot use nicotine replacement due to medical reasons, or are undergoing other tobacco treatments.Check my eligibility

What is being tested?

The study tests the effectiveness of combining MAPS-based telephone counseling with tailored text messages versus standard quitline smoking cessation treatment. Participants will receive either nicotine patches or lozenges as part of their therapy.See study design

What are the potential side effects?

Potential side effects from the interventions may include skin irritation from nicotine patches, mouth problems like soreness or hiccups from lozenges, and possible withdrawal symptoms such as irritability, cravings, or difficulty concentrating when quitting smoking.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

MAPS vs Standard Treatment in facilitating long term smoking abstinence

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Group 2: Motivation and Problem Solving (MAPS) counselingExperimental Treatment3 Interventions

Participants will receive a 12 week supply of nicotine replacement therapy (the patch and lozenges) along with the MAPS intervention, which consists of 6 MAPS counseling calls over 12 months, and individually tailored SMS text content driven by monthly smartphone delivered check-ins for 24 months

Group II: Group 1: Standard TreatmentActive Control3 Interventions

Participants will receive a connection to the Tobacco Free Florida Quitline and a 12 week supply of nicotine replacement therapy (the patch and lozenges)

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Nicotine patch

2015

Completed Phase 4

~7450

Nicotine Lozenge

2005

Completed Phase 4

~300

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor

543 Previous Clinical Trials

135,135 Total Patients Enrolled

James and Esther King Biomedical Research ProgramOTHER

13 Previous Clinical Trials

1,474 Total Patients Enrolled

Jennifer Vidrine, PhD, MSPrincipal InvestigatorMoffitt Cancer Center

Media Library

Motivation and Problem Solving (MAPS) intervention Clinical Trial Eligibility Overview. Trial Name: NCT05645146 — N/A

Cervical Cancer Research Study Groups: Group 2: Motivation and Problem Solving (MAPS) counseling, Group 1: Standard Treatment

Cervical Cancer Clinical Trial 2023: Motivation and Problem Solving (MAPS) intervention Highlights & Side Effects. Trial Name: NCT05645146 — N/A

Motivation and Problem Solving (MAPS) intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05645146 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial presently recruiting participants?

"Yes, the information hosted on clinicaltrials.gov verifies that this research project is presently seeking patients. This trial was first reported on November 17th 2022 and has been updated as recently as December 1st 2022. 360 participants are required to be enrolled from a single location."

Answered by AI

How many participants have been incorporated into this experiment?

"Affirmative. Information hosted on clinicaltrials.gov reveals that the trial - first posted November 17th 2022 - is actively seeking 360 participants from a single location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)

2022. "Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05645146.

All > Cervical Cancer